- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Acura Pharmaceuticals Inc
+ Add to WatchlistACUR:US
2.3100 USD 0.0300 1.28%As of 12:26:07 ET on 05/23/2013.
Snapshot for Acura Pharmaceuticals Inc (ACUR)
| Open: | 2.2700 | Day's Range: | 2.2500 - 2.3700 | Volume: | 169,558 |
|---|---|---|---|---|---|
| Previous Close: | 2.3400 | 52wk Range: | 1.0600 - 4.5000 | 1-Yr Rtn: | -19.79% |
Key Statistics for ACUR
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.2400 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 108.29 |
| Shares Outstanding (M) | 46.38 |
| 30 Day Average Volume | 1,045,020 |
| Price/Book (mrq) | 4.6446 |
| Price/Sale (ttm) | 26,960.5868 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ACUR
Company Profile & Key Executives for ACUR
Acura Pharmaceuticals Inc. is a pharmaceutical technology development company. The Company researches, develops, and manufactures active pharmaceutical ingredients (APIs) used as raw materials in the production of pharmaceutical products. Acura has developed technologies for use in narcotic-based pain management products.
| Robert B JonesPresident/CEO | Peter A ClemensSenior VP/CFO/Secretary |
| Robert A SeiserVP/Treasurer/Controller | Albert W BrzeczkoVP:Technical Affairs |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ACUR News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page